Advertisement

DCD Liver Transplant: The OPO Perspective

  • Danielle BalbisEmail author
  • Heather Markuson
Chapter
  • 12 Downloads

Abstract

Donation after circulatory death (DCD) provides the option of organ donation for patients who are not brain-dead, but for whom ventilator support will be removed for the purpose of death. With over 112,000 people waiting for a life-saving transplant, it is crucial that organ procurement organizations determine opportunities for the greatest potential for growth. For many, it is DCD donation. It is possible for DCD donors to donate the liver, kidneys, pancreas, lungs, and even the heart, but the most common organs recovered and transplanted from this donor population remain the liver and kidneys.

Key elements for a successful DCD program within an OPO are public education, hospital development, clear DCD policy creation within the donor hospitals that outlines an efficient referral and DCD process, excellent communication with transplant programs, highly proficient DCD organ recovery, packaging and transport, successful transplantation, and aftercare for the family. Public education should focus on encouraging people to register their donation decision so that their families do not have to make that decision for them. OPOs must provide hospital services personnel to assist hospital staff with the process of identifying patients who could be potential DCD organ donors and educating them on how and when to make the referral. OPOs must also respond to all referrals efficiently and provide the donor hospitals with a high level of service to their patients and families.

A DCD program within an OPO will become successful over time with practice and a significant amount of communication with families, donor hospitals, and transplant programs.

Keywords

OPO Procurement Organ recovery Hospital services Donor registry Donor management Liver allocation Donor family 

References

  1. 1.
    Reiner MA, Cornell D, Howard RJ. Development of a successful non-heart-beating organ donation program. Prog Transplant. 2003;13:225–30.PubMedGoogle Scholar
  2. 2.
  3. 3.
    Lewis J, et al. Development of the University of Wisconsin donation after cardiac death evaluation tool. Prog Transplant. 2003;13(4):265–73.CrossRefGoogle Scholar
  4. 4.
    Malinoski DJ, Daly MC, Patel MS, Oley-Graybill C, Foster CE III, Salim A. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. J Trauma. 2011;71(4):990–5, discussion 996CrossRefGoogle Scholar
  5. 5.
    Shahed T, et al. Organ donation after cardiac death in amyotropic lateral sclerosis. Ann Neurol. 2012;71(2):154–6.CrossRefGoogle Scholar
  6. 6.
    Institute of Medicine, National Academy of Sciences. Non-heart-beating organ transplantation: practice and protocols. Washington, D.C.: National Academy Press; 2000.Google Scholar
  7. 7.
    Bernat JL, D’Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, Rosenbaum SH, Devita MA, Gaston RS, Merion RM, Barr ML, Marks WH, Nathan H, O’connor K, Rudow DL, Leichtman AB, Schwab P, Ascher NL, Metzger RA, Mc Bride V, Graham W, Wagner D, Warren J, Delmonico FL. Report of a National Conference on donation after cardiac death. Am J Transplant. 2006;6:281.CrossRefGoogle Scholar
  8. 8.
    Organ Procurement and Transplant Network policies, updated 05/24/2019, https://optn.transplant.hrsa.gov/governance/policies.
  9. 9.
    U.S. Public Health Service Guidelines for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation, Centers for Disease Control and Prevention. MMWR Recomm Rep. 1994; 43(RR-8): 1–17.Google Scholar

Further Reading

  1. Bernat JL, et al. Circulatory death determination in uncontrolled organ donors: a panel viewpoint. Ann Emerg Med. 2014;63(1):89–90.CrossRefGoogle Scholar
  2. Grewal HP, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transplant. 2009;15:1028–35.CrossRefGoogle Scholar
  3. Howard RJ, Cornell D. Ethical Issues in Organ Procurement and Transplantation, Bioethics - Medical, Ethical and Legal Perspectives, Peter A. Clark, IntechOpen, DOI: 10.5772/64922. Available from: https://www.intechopen.com/books/bioethics-medical-ethical-and-legalperspectives/ethical-issues-in-organ-procurement-and-transplantation.
  4. Mathur AK, et al. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10:2512–9.CrossRefGoogle Scholar
  5. Seem DL, Lee I, Umscheid CA, Kuehnert MJ. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus and hepatitis C virus transmission through organ transplantation. Public Health Reports. 2013;128:247–344.CrossRefGoogle Scholar
  6. Sheehy E, Conrad SL, Brigham LE, Luskin R, Eakin M, Schkade L, Hunsicker L. Estimating the number of potential organ donors in the United States. N Engl J Med. 2003;349:667–74.CrossRefGoogle Scholar
  7. Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, Aranda-Michel J, Keaveny AP, Kramer DJ, Nguyen JH. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012;18:101–12.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.LifeQuest Organ Recovery ServicesGainesvilleUSA

Personalised recommendations